Disease remission of refractory vulvovaginal and gingival lichen planus with tildrakizumab
Author:
Affiliation:
1. Department of Dermatology Royal North Shore Hospital Sydney New South Wales Australia
Publisher
Wiley
Subject
Dermatology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajd.13553
Reference10 articles.
1. Tildrakizumab for the treatment of psoriasis
2. Recalcitrant lichen planopilaris and frontal fibrosing alopecia responding to tildrakizumab
3. Clinical healing of erosive oral lichen planus with tildrakizumab implicates the interleukin‐23/interleukin‐17 pathway in the pathogenesis of lichen planus
4. Therapeutic Targeting of Th17/Tc17 Cells Leads to Clinical Improvement of Lichen Planus
5. Immunoexpression of Interleukin-22 and Interleukin-23 in Oral and Cutaneous Lichen Planus Lesions: A Preliminary Study
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Tildrakizumab in Psoriasis and Beyond;Journal of Dermatology and Dermatologic Surgery;2024-01
2. Comparing quality of life in women with vulvovaginal lichen planus treated with topical and systemic treatments using the vulvar quality of life index;Australasian Journal of Dermatology;2023-04-10
3. Novel and Off-Label Biologic Use in the Management of Hidradenitis Suppurativa, Pyoderma Gangrenosum, Lichen Planus, and Seborrheic Dermatitis: A Narrative Review;Dermatology and Therapy;2022-11-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3